Welch Allyn, a medical device manufacturer based in Skaneateles Falls, New York, announced that it had received approval from the United States Food and Drug Administration for its iPhone PanOptic Ophthalmoscope. According to a press release by the company, the device is designed to work with the Apple iPhone and can be used by physicians to store, capture, retrieve and send images taken during routine eye exams.
The PanOptic viewing scope is designed for viewing the retinal nerve and the fundus of an undilated eye. Since the device uses the iPhone’s high-resolution screen, it provides a larger viewing area than a traditional ophthalmoscope. The device is designed for use with both the iPhone 4 and 4S. According to information from the company, the device can increase magnification 26 percent more than other ophthalmologic devices on the market. In addition to improved medical data sharing with patients, the iPhone attachment makes it easier for physicians to maintain compliance. The device is scheduled to ship starting February 11th, 2013. The system comprises both the PanOptic device and a software package called the iExaminer.
Rick Farchione is the senior manager of physical assessment at the company. In prepared remarks, he said, "It will increase workflow efficiency by allowing providers to capture and share images from any clinical environment. It is a low-cost way to digitally capture eye imaging and will also make it easier for providers to share images with their patients, helping to improve patient knowledge and compliance.”
- Portable Energy Solutions - Supplier Resource
- Discover How Practice Makes Perfect in IVD Development - Supplier Resource
- Line Marking - Supplier Resource
- Medtech M&As of 2014 Report - Supplier Resource
- Learn how GW Plastics Perfected the Design and Production of a Tissue Marker Device - Supplier Resource
- Learn Why Leading Healthcare Companies Rely on GW Plastics for Innovative Solutions, from Concept to Market - Supplier Resource